Chutian Shu, Ph.D.
Head of Chemistry, Manufacturing and Controls (CMC)


Chutian Shu is the Head of CMC at Terns China Biotechnology. Dr. Shu brings over fourteen years of chemistry and manufacturing experience from both global pharmaceutical and Chinese biotech companies. Prior to joining Terns, Dr. Shu held a senior leadership position in the department of Chemical & Analytical Development at Novartis. In this role, he was responsible for chemistry, manufacturing, and controls. Before Novartis, Dr. Shu was the Executive Director and Head of CMC at Xuanzhu Pharma, where he was responsible for CMC development and regulatory filings for innovative small molecule drug candidates. Earlier in his career, Dr. Shu was based in the US as a Principal Scientist at Boehringer-Ingelheim Pharmaceuticals.

Dr. Shu graduated with a bachelor’s degree in Polymer Chemistry from the University of Science and Technology of China (USTC) in Hefei, China. He went on to obtain his Ph.D. in Chemistry from Emory University and complete his postdoctoral training at Yale University.